Projecting the Long-term Clinical Value of Mavacamten for the Treatment of Obstructive Hypertrophic Cardiomyopathy in the United States: An Assessment of Net Health Benefit
- Resource Type
- Article
- Source
- In
Clinical Therapeutics January 2022 44(1):52-66 - Subject
- Language
- ISSN
- 0149-2918